Morgan Stanley Lannett CO Inc Transaction History

Morgan Stanley

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	BUY	$0.45 - $0.86 $333 - $636	740 Added 2.49%	30,470 $15,000
Q3 2022 Nov 14, 2022	SELL	$0.46 - $0.63 $12,131 - $16,614	-26,372 Reduced 47.01%	29,730 $14,000
Q2 2022 Oct 27, 2022	BUY	$0.47 - $0.87 $9,501 - $17,587	20,215 Added 56.33%	56,102 $33,000
Q2 2022 Aug 15, 2022	BUY	$0.47 - $0.87 $9,501 - $17,587	20,215 Added 56.33%	56,102 $33,000
Q1 2022 Oct 27, 2022	SELL	$0.75 - $1.77 $15,161 - $35,780	-20,215 Reduced 36.03%	35,887 $28,000
Q1 2022 May 13, 2022	SELL	$0.75 - $1.77 $118,077 - $278,661	-157,436 Reduced 81.44%	35,887 $28,000
Q4 2021 Feb 14, 2022	BUY	$1.56 - $2.93 $34,571 - $64,931	22,161 Added 12.95%	193,323 $313,000
Q3 2021 Nov 15, 2021	BUY	$2.91 - $4.83 $498,081 - $826,712	171,162 New	171,162 $513,000

Ticker LCI
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 42,960,000
Market Cap $1.29M
Description
Lannett Company, Inc. develops, manufactures, packages, markets, and distributes generic versions of brand pharmaceutical products in the United States. The company offers solid oral and extended release, topical, liquid, nasal, and oral solution finished dosage forms of drugs that address a range of therapeutic areas, as well as ophthalmic, nas...

Get notified when there are updates to the investment portfolio of Morgan Stanley, based on Form 13F filings with the SEC.

Stay updated on Morgan Stanley with notifications on news.